{"id":"W2102182787","doi":"10.1016/s1474-4422(11)70108-9","title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":638,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Actelion Pharmaceuticals","keywords":"Endothelin receptor antagonist; Medicine; Glasgow Outcome Scale; Subarachnoid hemorrhage; Placebo; Endovascular coiling; Clinical endpoint; Vasospasm; Anesthesia; Randomized controlled trial; Internal medicine; Aneurysm; Antagonist; Surgery; Endovascular treatment","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005167453,0.0003674116,0.001114729,0.0001757709,0.0002415304,0.00003499073,0.0003541167,0.0001875766,0.0003459448],"category_scores_gemma":[0.0000652123,0.000227601,0.0001694202,0.000244171,0.0002888397,0.0001230231,0.00005204879,0.0006713378,0.0000773181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003473182,"about_ca_system_score_gemma":0.0001397757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000764582,"about_ca_topic_score_gemma":0.0002913122,"domain_scores_codex":[0.9972297,0.0005795843,0.0006506878,0.0006003372,0.0002659749,0.0006737393],"domain_scores_gemma":[0.9982482,0.0004602705,0.0002831749,0.0007426099,0.00009330473,0.000172458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9772718,0.003050234,0.01714438,0.00002140768,0.00007107749,0.0005573353,0.0003479203,0.000007036572,0.0002758371,0.0007432627,0.00003294781,0.000476758],"study_design_scores_gemma":[0.9864171,0.009198894,0.002212305,0.000006154763,0.0003568028,0.0004199609,0.0000286938,0.0005196035,0.0002732054,0.0001243382,0.000213306,0.0002296466],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888011,0.00004073002,0.00003039392,0.002926058,0.000309491,0.005178847,0.00003060704,0.0001572436,0.00252554],"genre_scores_gemma":[0.9966739,0.00001812901,0.000132913,0.001302163,0.0007878941,0.0006533222,0.0001375181,0.00005227429,0.0002418431],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01493208,"threshold_uncertainty_score":0.9281301,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0542099779558352,"score_gpt":0.2981004877135117,"score_spread":0.2438905097576765,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}